|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
÷�� |
|
����,ϸ�� |
|
ϸ�������� |
| ��������������� | |
|
������ |
|
���ػ� |
| PubMed | |
|
Article by |
|
Article by |
÷����ϸ�������о���չ
������, ���ػ�
����ҽѧԺ����߮�ɽҽԺƤ����, ����ʡ�ߺ��� 241001
÷�����ߵ�ϸ������״̬��Ӱ���䲡�鷢������չ��ת�����Ҫ����֮һ.��ͬ����÷�����ߴ���һϵ��ϸ�����߹���ʧ����ϸ��������������,�ɱ���Ϊ�ֲ�������Ѫ��Th/Ts�����½�,Th1/Th2��ʧ�⼰��ϸ�����ӷ���ʧ��,Ѫ���������2����ˮƽ�ı仯��.��ʾ�ʵ���ϸ�����ߵ��ڽ�������÷��������.
[2] Salazar JC, Hazlett KR, Radolf JD. The immune response to infection with Treponema pallidum, the stealth pathogen. Microbes Infect,2002, 4:1133-1140.
[3] Van Voorhis WC, Barrett LK, Nasio JM, et al. Lesions of primary and secondary syphilis contain activated cytolytic T cells. Infect Immun, 1996, 64:1048-1050.
[4] McBroom RL, Styles AR, Chiu M J, et al. Secondary syphilis in persons infected with and not infected with HIV 1:a comparative immunohistologic study. Am J Dermatopathol, 1999, 21:432-441.
[5] Wenhai L, Jianzhong Z, Cao Y. Detection of Treponema pallidum in skin lesions of secondary syphilis and characterization of the inflammatory infiltrate. Dermatology, 2004, 208:94-97.
[6] Guarner J, Greer PW, Bartlett J, et al. Congenital syphilis in a newborn:an immunopathologic study. Mod Pathol, 1999, 12:82-87.
[7] Koga T, Duan H, Moroi Y, et al. Activated and mature CD83-positive dendritic cells and interferon-gamma-positive cells in skin eruptions of secondary syphilis. Acta Derm Venereol, 2003, 83:214.
[8] Sellati TJ, Waldrop SL, Salazar JC,et al. The cutaneous response in humans to Treponema pallidum lipoprotein analogues involves cellular elements of both innate and adaptive immunity. J Immunol, 2001,166:4131-4140.
[9] Pope V, Larsen SA, Rice RJ, et al. Flow cytometric analysis of peripheral blood lymphocyte immunophenotypes in persons infected with Treponema pallidum. Clin Diagn Lab Immunol, 1994, 1:121-124.
[10] Yang RD, Cheng JP, Tian GN, et al. Detection of peripheral blood lymphocyte subsets in treated syphilis patients with persistent positivity for rapid plasma reagin. Di Yi Jun Yi Da Xue Xue Bao, 2003, 23:1307-1309.
[11] Fitzgerald TJ. The Th1/Th2-like switch in syphilitic infection:is it detrimental? Infect Immun, 1992, 60:3475-3479.
[12] Van Voorhis WC, Barrett LK, Koelle DM, et al. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J Infect Dis,1996, 173:491-495.
[13] Marra CM, Castro CD, Kuller L, et al. Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model.Neurology, 1998, 51:957-961.
[14] Arroll TW, Centurion-Lara A, Lukehart SA, et al. T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection. Infect Immun, 1999, 67:4757.
[15] Wicher V, Scarozza AM, Ramsingh AI, et al. Cytokine gene expression in skin of susceptible guinea-pig infected with Treponema pallidum. Immunology, 1998, 95:242-247.
[16] Podwinska J, Zaba R, Chomik M, et al. The ability of peripheral blood mononuclear cells(PBMC)of syphilitic patients to produce IL-2. FEMS Immunol Med Microbiol, 1995, 12:17-27.
[17] Podwinska J, Lusiak M, Zaba R,et al. The pattern and level of cytokines secreted by Th1 and Th2 lymphocytes of syphilitic patients correlate to the progression of the disease. FEMS Immunol Med Mierobiol,2000, 28:1-14.
[18] Lusiak M, Podwinska J. Interleukin 10 and its role in the regulation of the cell-mediated immune response in syphilis. Arch Immunol Ther Exp(Warsz), 2001,49:417-421.